封面
市场调查报告书
商品编码
1544765

远距医疗市场、机会、成长动力、产业趋势分析与预测,2024-2032

Telemedicine Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在电信和数位医疗技术创新的推动下,2024 年至 2032 年间,全球远距医疗市场规模的复合年增长率将达到 16.4%。高速互联网、先进的远距医疗平台和穿戴式健康设备等先进技术使远距咨询更加高效和便利。此外,不断增加的政府支持和有利的法规透过促进远距医疗融入主流医疗保健进一步推动市场成长。这些支持性措施,加上数位医疗解决方案的推动,将扩大远距医疗服务,提高医疗保健可近性,并改善患者的治疗效果。

例如,2024 年 1 月,北哈萨克地区推出了新的远距医疗综合体,以增强农村人口获得专业医疗咨询的机会,旨在改善偏远地区的医疗保健可用性。这项发展凸显了在全球扩大远距医疗服务的更广泛趋势,旨在缩小医疗保健取得方面的差距,并为服务不足的人群提供专业咨询。这表明对远距医疗解决方案的需求不断增长,以加强医疗保健服务,特别是在农村和偏远地区,从而推动了全球远距医疗产业的成长。

远距医疗市场根据组件、专业、最终用途和地区进行细分。

在糖尿病和甲状腺疾病等慢性内分泌疾病发病率上升的推动下,内分泌学领域将在 2024 年至 2032 年期间大幅增加。远距医疗有助于远端管理和监控,这对于管理此类疾病以及为患者提供及时的护理和定期检查至关重要。虚拟咨询的便利性和远端监控技术的进步正在推动内分泌学的广泛采用,有助于其在远距医疗市场中的主导地位。

由于远距医疗服务的需求不断增长,到 2032 年,服务领域将显着成长。这包括虚拟咨询、远端诊断和患者监护,为满足各种医疗保健需求的患者提供便利和可近性。远距医疗服务的扩展与数位医疗技术的进步相结合,支持高效且有效的护理服务。随着越来越多的医疗保健提供者采用远距医疗解决方案,服务领域持续成长,反映出其在市场中的关键作用。

由于人口众多且多样化、智慧型手机普及率不断提高以及偏远地区医疗保健需求不断增长,亚太地区远距医疗市场份额将在 2024 年至 2032 年实现适度的复合年增长率。该地区的快速城市化,加上政府的支持性倡议和数位医疗基础设施投资的增加,正在进一步推动远距医疗的采用。此外,不断扩大的医疗保健需求和推动创新解决方案来缩小医疗保健获取差距,使亚太地区成为远距医疗市场成长的重要贡献者。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率增加
      • 智慧型手机用户数量不断成长
      • 与行动电话和互联网相关的技术进步
      • 更需要节省医疗服务成本
      • 有利的政府措施国家
    • 产业陷阱与挑战
      • 安全和隐私问题
  • 成长潜力分析
  • 报销场景
    • 我们
    • 欧洲
  • 远距医疗方式
  • 远距医疗项目
  • 远距医疗倡议
  • 远距医疗未来趋势
  • 分析师建议
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按组成部分,2021 - 2032 年

  • 主要趋势
  • 硬体
  • 软体
    • 基于云端
    • 本地
  • 服务
    • 远距咨询
    • 远端监控
    • 远距教育/培训
    • 其他服务

第 6 章:市场估计与预测:按专业划分,2021 - 2032 年

  • 主要趋势
  • 肺部
  • 精神病学
  • 心臟病学
  • 内分泌科
  • 风湿病学
  • 妇科
  • 胃肠病学
  • 肿瘤学
  • 其他专业

第 7 章:市场估计与预测:按最终用户划分,2021 - 2032 年

  • 主要趋势
  • 医疗保健提供者
    • Hospitals and clinics
    • Long-term care centers
    • Other healthcare facilities
  • 付款人
  • 患者
  • 其他最终用户

第 8 章:市场估计与预测:按地区划分,2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 波兰
    • 比利时
    • 瑞典
    • 瑞士
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 9 章:公司简介

  • AMC Health
  • AMD Global Telemedicine
  • American Well (Amwell)
  • Cisco Systems, Inc.
  • Eagle Telemedicine
  • GE HealthCare Technologies, Inc.
  • Health Catalyst Inc.
  • HIPAAVIDEO.net, Inc.
  • Honeywell International Inc
  • Koninklijke Philips N.V
  • Masimo Corporation
  • McKesson Medical-Surgical Inc.
  • Mend
  • OBS Medical
  • Oracle Corporation (Cerner)
  • RemetricHealth
  • SOC Telemed (Patient Square Capital)
  • Specialist Telemed
  • Teladoc Health, Inc.
  • Updox
  • VCDoctor
  • Veradigm LLC (Allscripts Healthcare Solutions Inc.)
简介目录
Product Code: 3129

Global Telemedicine Market size will capture a 16.4% CAGR between 2024 and 2032, driven by innovations in telecommunication and digital health technologies. Advances, such as high-speed internet, sophisticated telemedicine platforms, and wearable health devices enable more efficient and accessible remote consultations. Also, increasing government support and favorable regulations further drive market growth by facilitating the integration of telemedicine into mainstream healthcare. These supportive measures, along with a push for digital health solutions, will expand telemedicine services, enhance healthcare accessibility, and improve patient outcomes.

For instance, in January 2024, the North Kazakhstan Region introduced new telemedicine complexes to enhance access to specialized medical consultations for its rural population, aiming to improve healthcare availability in remote areas. This development underscores a broader trend of expanding telemedicine services globally, aiming to bridge gaps in healthcare access and provide specialized consultations to underserved populations. It indicates a rising demand for telemedicine solutions to enhance healthcare delivery, particularly in rural and remote regions, driving growth in the global telemedicine industry.

The telemedicine market is segmented based on component, specialty, end-use, and region.

The endocrinology segment will witness substantial growth throughout 2024-2032, fueled by the rising incidence of chronic endocrine conditions like diabetes and thyroid disorders. Telemedicine facilitates remote management and monitoring, essential for managing such conditions and providing patients with timely access to care and regular check-ups. The convenience of virtual consultations and advancements in remote monitoring technology are driving increased adoption in endocrinology, thereby contributing to its dominant position in the telemedicine market.

The services segment will amass remarkable gains by 2032, owing to the growing demand for remote healthcare services. This includes virtual consultations, remote diagnostics, and patient monitoring, which provide convenience and accessibility for patients across various healthcare needs. The expansion of telehealth services, in tandem with advancements in digital health technologies, supports efficient and effective care delivery. As more healthcare providers adopt telemedicine solutions, the services segment continues to grow, reflecting its pivotal role in the market.

Asia Pacific telemedicine market share will achieve a moderate CAGR from 2024 to 2032 due to its large and diverse population, increasing smartphone penetration, and growing demand for healthcare access in remote areas. The region's rapid urbanization, in line with supportive government initiatives and rising investments in digital health infrastructure, is further driving telemedicine adoption. Besides, the expanding healthcare needs and the push for innovative solutions to bridge gaps in healthcare access establish Asia Pacific as a significant contributor to the telemedicine market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360º synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Growing number of smartphone users
      • 3.2.1.3 Technological advancements related to mobile phones and internet
      • 3.2.1.4 Greater need for cost-saving in healthcare delivery
      • 3.2.1.5 Favorable government initiatives countries
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Security and privacy concerns
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Telemedicine modalities
  • 3.6 Telemedicine projects
  • 3.7 Telemedicine initiatives
  • 3.8 Telemedicine future trends
  • 3.9 Analyst recommendations
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hardware
  • 5.3 Software
    • 5.3.1 Cloud-based
    • 5.3.2 On-premises
  • 5.4 Services
    • 5.4.1 Tele-consultation
    • 5.4.2 Tele-monitoring
    • 5.4.3 Tele-education/training
    • 5.4.4 Other services

Chapter 6 Market Estimates and Forecast, By Specialty, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pulmonary
  • 6.3 Psychiatry
  • 6.4 Cardiology
  • 6.5 Endocrinology
  • 6.6 Rheumatology
  • 6.7 Gynecology
  • 6.8 Gastroenterology
  • 6.9 Oncology
  • 6.10 Other specialties

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Healthcare providers
    • 7.2.1 Hospitals and clinics
    • 7.2.2 Long-term care centers
    • 7.2.3 Other healthcare facilities
  • 7.3 Payers
  • 7.4 Patients
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Poland
    • 8.3.7 Belgium
    • 8.3.8 Sweden
    • 8.3.9 Switzerland
    • 8.3.10 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 AMC Health
  • 9.2 AMD Global Telemedicine
  • 9.3 American Well (Amwell)
  • 9.4 Cisco Systems, Inc.
  • 9.5 Eagle Telemedicine
  • 9.6 GE HealthCare Technologies, Inc.
  • 9.7 Health Catalyst Inc.
  • 9.8 HIPAAVIDEO.net, Inc.
  • 9.9 Honeywell International Inc
  • 9.10 Koninklijke Philips N.V
  • 9.11 Masimo Corporation
  • 9.12 McKesson Medical-Surgical Inc.
  • 9.13 Mend
  • 9.14 OBS Medical
  • 9.15 Oracle Corporation (Cerner)
  • 9.16 RemetricHealth
  • 9.17 SOC Telemed (Patient Square Capital)
  • 9.18 Specialist Telemed
  • 9.19 Teladoc Health, Inc.
  • 9.20 Updox
  • 9.21 VCDoctor
  • 9.22 Veradigm LLC (Allscripts Healthcare Solutions Inc.)